https://www.fool.com/investing/2024/02/28/24-top-stocks-to-buy-now-in-march-2024/?source=iedfolrf0000001
Feb 28, 2024 - This list of specular stocks includes growth stocks, dividend stocks, and, perhaps best of all, artificial intelligence stocks.
0
fool:-671664678332837850
0
https://www.zacks.com/stock/news/2233459/salesforce-hp-snowflake-all-down-on-reported-earnings?cid=CS-ZC-FT-ahead_of_wall_street-2233459
Feb 28, 2024 - Shares of Snowflake (SNOW) have fallen precipitously, nearly -25%, on the news that its CEO, Frank Slootman, would retire after 5 years on the job.
zc:-3000729208598281344
0
https://www.zacks.com/stock/news/2233414/here-s-what-key-metrics-tell-us-about-salesforce-com-crm-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2233414
Feb 28, 2024 - While the top- and bottom-line numbers for Salesforce.com (CRM) give a sense of how the business performed in the quarter ended January 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:1846154991689813505
0
https://www.fool.com/investing/2024/02/28/10-best-growth-stocks-to-buy-now-in-march/?source=iedfolrf0000001
Feb 28, 2024 - Investing in these spectacular growth stocks has a good chance of increasing your wealth over the long term.
0
fool:3482312909431239032
0
https://www.zacks.com/stock/news/2233291/q4-gdp-and-consumption-revisions?cid=CS-ZC-FT-economic_highlights-2233291
Feb 28, 2024 - Q4 GDP and Consumption Revisions
zc:1117305999935997355
0
https://www.zacks.com/stock/news/2233287/q4-gdp-trade-deficit-both-dip-tjx-beats-in-q4?cid=CS-ZC-FT-ahead_of_wall_street-2233287
Feb 28, 2024 - The first revision to Q4 GDP came in 10 bps light of estimates and the previous print.
zc:4476566468684236063
0
https://www.zacks.com/commentary/2231762/top-stock-reports-for-jpmorgan-chase-salesforce-vertex-pharmaceuticals?cid=CS-ZC-FT-research_daily-2231762
Feb 26, 2024 - Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Salesforce, Inc. (CRM) and Vertex Pharmaceuticals Incorporated (VRTX).
zc:-5343308729693302277
0
https://www.zacks.com/stock/news/2231826/wall-street-awaits-pce-core-pce-data?cid=CS-ZC-FT-economic_highlights-2231826
Feb 26, 2024 - Wall Street Awaits PCE/Core PCE Data
zc:2562279806360416622
0
https://www.zacks.com/stock/news/2231814/pre-markets-up-to-start-a-new-trading-week?cid=CS-ZC-FT-ahead_of_wall_street-2231814
Feb 26, 2024 - The all-important Personal Consumption Expenditures (PCE) on Thursday will take center stage, as it is the Fed's favored metric for tracking inflation.
zc:3990009207302334106
0
https://www.zacks.com/stock/news/2230841/what-analyst-projections-for-key-metrics-reveal-about-salesforce-com-crm-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2230841
Feb 23, 2024 - Besides Wall Street's top -and-bottom-line estimates for Salesforce.com (CRM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended January 2024.
zc:8803248332265566930
0